In a recent clinical trial after the onset of T1DM, monotherapy with human anti-TNF-α showed a mild effect on preserved C-peptide concentration as a surrogate for insulin secretion after a mixed meal [25]. This evidence concerns the gene TNF and type 1 diabetes mellitus.